Bitech Technologies Corp Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Bitech Technologies Corp has filed its Q1 2024 10-Q report, detailing financial data and historical company name changes.</b>

AI Summary

Bitech Technologies Corp (BESS-WT) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Bitech Technologies Corp filed a 10-Q report for the period ending March 31, 2024. The company was formerly known as Spine Injury Solutions, Inc., Spine Pain Management, Inc., and VERSA CARD, INC. The filing includes data related to common stock, preferred stock, additional paid-in capital, and retained earnings for various periods. Specific dates mentioned include October 7, 2015, December 1, 2009, and May 15, 2008, related to company name changes. The company's business address is 895 Dove Street, Suite 300, Newport Beach, CA 92660.

Why It Matters

For investors and stakeholders tracking Bitech Technologies Corp, this filing contains several important signals. This filing provides an update on Bitech Technologies Corp's financial position and equity structure as of March 31, 2024. Understanding the company's historical name changes can provide context for its evolution and potential strategic shifts.

Risk Assessment

Risk Level: low — Bitech Technologies Corp shows low risk based on this filing. The filing is a standard 10-Q, providing routine financial disclosures without immediate red flags.

Analyst Insight

Review the detailed financial statements within the 10-Q to assess Bitech Technologies Corp's current financial health and equity structure.

Key Numbers

• 2024-03-31 — Reporting Period End Date (Conformed period of report)
• 2024-05-15 — Filing Date (Date the 10-Q was filed)
• 2024-01-01 — Quarter Start Date (Beginning of the reporting quarter)
• 2023-12-31 — Previous Year End Date (End of the previous fiscal year)

Key Players & Entities

• Bitech Technologies Corp (company) — Filer of the 10-Q report
• Spine Injury Solutions, Inc. (company) — Former name of Bitech Technologies Corp
• Spine Pain Management, Inc (company) — Former name of Bitech Technologies Corp
• VERSA CARD, INC. (company) — Former name of Bitech Technologies Corp
• Newport Beach (location) — City of Bitech Technologies Corp's business address

FAQ

Key Dates

• 2024-03-31: Quarterly Report End Date — Marks the end of the reporting period for the 10-Q.
• 2024-05-15: Filing Date — The date the 10-Q was officially submitted to the SEC.
• 2015-10-07: Name Change — Date Bitech Technologies Corp changed from Spine Injury Solutions, Inc.

Glossary

10-Q

A quarterly report required by the U.S. Securities and Exchange Commission (SEC). (Provides a comprehensive overview of a company's financial performance during a specific quarter.)

Common Stock

A security that represents ownership in a corporation. (Key component of a company's equity structure, detailed in the filing.)

Preferred Stock

A class of ownership in a corporation that has a higher claim on assets and earnings than common stock. (Represents another class of ownership, important for understanding the company's capital structure.)

Filing Documents

• form10-q.htm (10-Q) — 515KB
• ex31-1.htm (EX-31.1) — 9KB
• ex31-2.htm (EX-31.2) — 9KB
• ex32-1.htm (EX-32.1) — 4KB
• ex32-2.htm (EX-32.2) — 5KB
• 0001493152-24-019929.txt (&nbsp;) — 2644KB
• bttc-20240331.xsd (EX-101.SCH) — 19KB
• bttc-20240331_cal.xml (EX-101.CAL) — 23KB
• bttc-20240331_def.xml (EX-101.DEF) — 85KB
• bttc-20240331_lab.xml (EX-101.LAB) — 186KB
• bttc-20240331_pre.xml (EX-101.PRE) — 153KB
• form10-q_htm.xml (XML) — 277KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3. Quantitative and Qualitative Disclosure About Market Risk 20 Item 4.

Controls and Procedures

Controls and Procedures 20 PART II OTHER INFORMATION 21 Item 1.

Legal Proceedings

Legal Proceedings 21 Item 1A.

Risk Factors

Risk Factors 22 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 22 Item 3. Defaults Upon Senior Securities 22 Item 4. Mine Safety Disclosures 22 Item 5. Other Information 22 Item 6. Exhibits 23

Signatures

Signatures 25 2 Table of Contents NOTE ABOUT FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, among other things, statements regarding plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other than statements of historical facts. Forward-looking statements may appear throughout this report, including without limitation, Item 2 "Management's Discussion and Analysis of Financial Condition and Results of Operations." Forward-looking statements generally can be identified by words such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "will be," "will continue," "will likely result," and similar expressions. These forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this report and in our Annual Report on Form 10-K for the year ended December 31, 2022, and in particular, the risks discussed under the caption "Risk Factors" in Item 1A of this report and in in our Form 10-K, and those discussed in other documents we file with the Securities and Exchange Commission ("SEC"). Important factors that in our view could cause material adverse effects on our financial condition and results of operations include, but are not limited to, risks associated with service demands and acceptance, our ability to expand, changes in healthcare practices, changes in technology, economic conditions, the impact of competition and pricing, government regulation and approvals, impacts and disruptions caused by the COVID-19 pandemi

View Full Filing

View this 10-Q filing on SEC EDGAR